Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the ...

Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good.

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.

The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing ...

U.S. venture capital firms are no longer waiting for Chinese biotech assets to surface before investing in them — they’re ...

Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...

Shares of IO Biotech, Inc. IOBT are plummeting Tuesday after the company announced it filed for Chapter 7 bankruptcy and will ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for GMP cleanroom environments. Purpose built for GMP cleanroom environments, ...

CNBC's Angelica Peebles reports the latest news surrounding Big Pharma.